Analysts aren't deterred though, including Citi 's Yigal Nochomovitz, who recently raised his price target on CRSPR from $82 ...
Anthropic’s announcement of a ‘Claude-led’ CRISPR-like discovery is sparking controversy. Here’s why
Anthropic’s claim its AI agents discovered an unusual pattern in viral DNA similar to what’s seen in the gene-editing tool ...
A patient in Germany has been successfully treated with a drug based on CRISPR gene-editing technology for the first time ...
Anthropic's Claude autonomously found a CRISPR-like enzyme system called ART. Its function is unproven, and several ...
Clarke famously wrote, "Any sufficiently advanced technology is indistinguishable from magic." Kraig's approach gives that observation a wonderfully small, many-legged illustration. On September 29, ...
Four physician scientists and a molecular geneticist from HMS and the NIH were honored last week with the 2026 Warren Alpert ...
CRISPR diagnostics merge point-of-care and molecular testing, enabling rapid, low-cost detection, frontline protocol disruption and emerging investment opportunities.Dublin, Oct. 02, 2026 (GLOBE ...
Antimicrobial resistance is a major global health threat, with disproportionate impact in regions with limited diagnostic ...
BCC Research examines how AI is improving gene transfer technologies through data-driven design, delivery optimization and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results